Cardamonin Regulates miR-21 Expression and Suppresses Angiogenesis Induced by Vascular Endothelial Growth Factor

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Cardamonin exhibits anti-cancer properties by modulating cell survival, proliferation, and angiogenesis.
• Previous research demonstrated cardamonin's ability to suppress vascular endothelial growth factor (VEGF)-induced angiogenesis.
• MicroRNAs (miRNAs) are recognized as key regulators of angiogenesis.

Purpose of the Study:

• To investigate the potential role of miRNAs in the anti-angiogenic effect of cardamonin.
• To determine if cardamonin's anti-angiogenic activity in human umbilical vein endothelial cells (HUVECs) is linked to miRNA modulation.

Main Methods:

• Utilized human umbilical vein endothelial cells (HUVECs) treated with VEGF and cardamonin.
• Assessed the impact of cardamonin on miR-21 expression.
• Employed miR-21 mimics and inhibitors to elucidate the role of miR-21 in angiogenesis.

Main Results:

• Cardamonin significantly reduced VEGF-induced miR-21 expression in HUVECs.
• Restoration of miR-21 levels using mimics counteracted cardamonin's inhibitory effects on proliferation, migration, and angiogenesis.
• Inhibition of miR-21 using inhibitors reversed these effects, highlighting miR-21's crucial role.

Conclusions:

• The anti-angiogenic effect of cardamonin against VEGF-induced processes in HUVECs is mediated, at least in part, by the modulation of miR-21.
• This study provides novel insights into the preliminary mechanism of cardamonin's anti-angiogenic action.
• miR-21 is a key player in the anti-angiogenic pathway influenced by cardamonin.